Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2025-12-25 @ 1:12 PM
NCT ID: NCT00979459
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00979459
Study Brief: A Study of the Pharmacokinetics of Two Formulations of MK-1006 (MK-1006-010 AM1)(COMPLETED)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
MK-1006 80 mg FCT Participants received a single dose of two MK-1006 40 mg film coated tablets None None 0 12 7 12 View
MK-1006 80 mg DFC Participants received a single dose of four MK-1006 20 mg dry filled capsules None None 0 12 6 12 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Dyspepsia None Gastrointestinal disorders MedDRA 15.0 View
Nausea None Gastrointestinal disorders MedDRA 15.0 View
Chest Pain None General disorders MedDRA 15.0 View
Infusion Site Haematoma None General disorders MedDRA 15.0 View
Infusion Site Inflammation None General disorders MedDRA 15.0 View
Infusion Site Pain None General disorders MedDRA 15.0 View
Vessel Puncture Site Haematoma None General disorders MedDRA 15.0 View
Hypersensitivity None Immune system disorders MedDRA 15.0 View
Decreased Appetite None Metabolism and nutrition disorders MedDRA 15.0 View
Hypoglycaemia None Metabolism and nutrition disorders MedDRA 15.0 View
Back Pain None Musculoskeletal and connective tissue disorders MedDRA 15.0 View
Neck Pain None Musculoskeletal and connective tissue disorders MedDRA 15.0 View
Dizziness None Nervous system disorders MedDRA 15.0 View
Headache None Nervous system disorders MedDRA 15.0 View
Urticaria None Skin and subcutaneous tissue disorders MedDRA 15.0 View